期刊文献+

铜绿假单胞菌耐亚胺培南相关基因OprD_2研究 被引量:5

A Study of the OprD_(2) Gene of Pseudomonas Aeruginosa in Relation to Its Tolerance to Imipenem
下载PDF
导出
摘要 目的研究铜绿假单胞菌对亚胺培南的耐药机制。方法取临床分离的铜绿假单胞菌18株,经K-B法检测耐药性,根据耐药性分为耐亚胺培南菌组12株和敏感菌组6株。另设1标准菌株ATCC27853。采用PCR法检测各菌株的OprD2基因,探讨OprD2基因突变与细菌对亚胺培南耐药之间的关系。结果12株耐药菌经OprD2基因扩增,8株阴性,4株阳性;6株敏感菌株及标准菌株扩增全部为阳性。统计学检验结果表明,对亚胺培南耐药菌组和敏感菌组OprD2基因阳性率的差异有极显著性(P<0.01),且在耐药菌中发现了新的OprD2基因突变方式。结论OprD2突变是铜绿假单胞菌对亚胺培南耐药的重要机制,突变的方式有缺失突变与插入失活。 Objective To study the gene-level mechanism underlying the imipenem-resistance of pseudomonas aeruginosa(PA). Methods A PCR method was used to detect the OprD2 gene in PA. The relationship between the mutation of OprD2 and drug-tolerance of the bacteria was investigated in 12 strains of imipenem-resistant and 6 strains of imipenemsensitive PA isolated in the clinic. Meanwhile, a standard strain of PA ATCC27853 was also studied. The results were analyzed with the Chi-square test. Results 8 of 12 strains of imipenem-tolerant PA were shown to be negative for the OprD2 gene while 4 of them were positive. In contrast, all of the 6 strains of the imipenem-sensitive PA were found to be positive for the OprD2 gene, and so was the standard strain ATCC27853. The results of Chi-square test revealed that the difference between the positive rates of the OprD2 gene in the imipenem-tolerant and sensitive PA was statistically highly significant. Besides, a new type of the OprD2 mutation was discovered in the drug-tolerant PA. Conclusion Mutation of OprD2 was shown to be an important mechanism underlying the imipenem-tolerance of PA. 2 types of OprD2 mutation were found in the study, the deletion mutation and the insertion mutation.
出处 《医药导报》 CAS 2006年第2期102-104,共3页 Herald of Medicine
关键词 亚胺培南 铜绿假单胞菌 OprD2基因 基因突变 细菌耐药 Imipenem Pseudomonas aeruginosa OprD2 gene Mutation Drug-tolerance
  • 相关文献

参考文献9

  • 1Leidal K G, Munson K L, Johnson M C, et al. Metalloproteases from Pseudomonas aeruginosa degrade human RANTES, MCP-1, and ENA-78 [ J ]. J Interferon Cytokine Res ,2003,23(6) :307 -318.
  • 2Woodford N, Palpou M F, Babini G S, et al. Carbapenemaseproducing Pseudomonas aeruginosa in UK [ J ]. Lancet,1998,352(9127 ) :546.
  • 3NCCLS. Performance standards for antimicrobial susceptibility testing, Ninth informational supplement, NCCLS document M100-S9[S]. 1999, 19:36 -75.
  • 4Pimay J P, De V D, Mossialos D, et al. Analysis of the Pseudomonas aeruginosa OprD gene from clinical and environmental isolates [ J ]. Environ Microbiol, 2002, 4(12) :872 -882.
  • 5Garciade L J, Navarro D, Gimcno C. Penetration of meropenem in gram-negative bacilli. Differences in activity with imipenem [ J ]. Enferm lnfecc Microbiol Clin, 1997,15 ( 9 ) :14 - 19.
  • 6Nikaino H. Prevention of drug access to bacterial targets:permeability barriers and active efflux[J]. Science, 1994,264(4) :382.
  • 7Ochs M M, Mccusker M P, Bains M, et al. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids [ J ].Antimicrob Agents Chemother, 1999,43 ( 5 ) : 1085 - 1090.
  • 8Kiyomi O, Naomasa G, Takeshi N. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay[ J]. Antimicrobial Agents Chemother,2001,45(7) : 1964 - 1971.
  • 9Wolter D J, Hanson N D, Lister P D. Insertional inactivation of OprD in clinical isolates of pseudomonas aeruginosa leading to carbapenem resistance [ J ]. FEMS Microbiol Lett,2004,236( 1 ) : 137 - 143.

同被引文献30

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部